Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Linda Yau"'
Autor:
Heinz-Josef Lenz, Christoph Mancao, Frank Scappaticci, Nicholas Choong, Ivan Bosanac, Edith P. Mitchell, James Knost, Han Koh, Linda Yau, Fa-Chyi Lee, Aparna R. Parikh
Purpose:MAVERICC compared the efficacy and safety of modified leucovorin/5-fluorouracil/oxaliplatin plus bevacizumab (mFOLFOX6-BV) with leucovorin/5-fluorouracil/irinotecan plus bevacizumab (FOLFIRI-BV) in patients with previously untreated metastati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a1220ff4a50a2bdc012c46a98527180
https://doi.org/10.1158/1078-0432.c.6526772
https://doi.org/10.1158/1078-0432.c.6526772
Autor:
Heinz-Josef Lenz, Christoph Mancao, Frank Scappaticci, Nicholas Choong, Ivan Bosanac, Edith P. Mitchell, James Knost, Han Koh, Linda Yau, Fa-Chyi Lee, Aparna R. Parikh
Supplementary Data from MAVERICC, a Randomized, Biomarker-stratified, Phase II Study of mFOLFOX6-Bevacizumab versus FOLFIRI-Bevacizumab as First-line Chemotherapy in Metastatic Colorectal Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07a1de47910677184ec570ca5a82537a
https://doi.org/10.1158/1078-0432.22467890.v1
https://doi.org/10.1158/1078-0432.22467890.v1
Autor:
Lavannya Pandit, Julia Garcia-Diaz, Gerard J. Criner, Benjamin Kramer, Jamie Freedman, Maria F. González-Lara, Rachel Baden, Linda Yau, Jian Han, Shalini V. Mohan, Miriam L Cameron, Reena Shah, Carlos Salama, Victoria Chávez, Martha Mekebeb-Reuter, Ferdinando Lima de Menezes, Jeffrey D. Neidhart, Emma Kaplan-Lewis, W. Reiss, Beverly Assman
Publikováno v:
New England Journal of Medicine
The New England Journal of Medicine
The New England Journal of Medicine
Background Coronavirus disease 2019 (Covid-19) pneumonia is often associated with hyperinflammation. Despite the disproportionate incidence of Covid-19 among underserved and racial and ethnic minority populations, the safety and efficacy of the anti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::945cc410d68f153659cd71656758fd56
https://doi.org/10.1056/nejmoa2030340
https://doi.org/10.1056/nejmoa2030340
Autor:
Abdelkader Rahmaoui, Aristides Maniatis, Dalia Moawad, Valerie Quarmby, Linda Yau, Martin Vanderlaan, Craig Azzolino, Cynthia Woods, Robert C. Olney
Publikováno v:
Clinical Pharmacology and Therapeutics
Manufacturing process changes may alter the characteristics of a protein therapeutic. In 2009, somatropin (version 1.0), a recombinant human growth hormone therapeutic, underwent a manufacturing update (version 1.1). The immunogenicity of somatropin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e642f8f057234b962a813ded8d1c192
http://europepmc.org/articles/PMC7158213
http://europepmc.org/articles/PMC7158213
Autor:
Ferdinando Lima de Menezes, W. Reiss, Emma Kaplan-Lewis, Maria F. González-Lara, Beverly Assman, Miriam L. Cameron, Linda Yau, Reena Shah, Gerard J. Criner, Jian Han, Julia Garcia-Diaz, Jamie Freedman, Martha Mekebeb-Reuter, Benjamin Kramer, Rachel Baden, Shalini V. Mohan, Victoria Chávez, Jeffrey D. Neidhart, Lavannya M. Pandit, Carlos Salama
BackgroundCoronavirus disease 2019 (Covid-19) pneumonia is often associated with hyperinflammation. Safety and efficacy of the anti–interleukin-6 receptor antibody tocilizumab was evaluated in patients hospitalized with Covid-19 pneumonia.MethodsNo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d4ade2fe46511f13e8cfbe55a0f84968
https://doi.org/10.1101/2020.10.21.20210203
https://doi.org/10.1101/2020.10.21.20210203
Autor:
Edith P. Mitchell, Nicholas Choong, Linda Yau, James A. Knost, Christoph Mancao, Han Koh, Fa-Chyi Lee, Heinz-Josef Lenz, Aparna Raj Parikh, Frank A. Scappaticci, Ivan Bosanac
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research, vol 25, iss 10
Clin Cancer Res
Clin Cancer Res
Purpose: MAVERICC compared the efficacy and safety of modified leucovorin/5-fluorouracil/oxaliplatin plus bevacizumab (mFOLFOX6-BV) with leucovorin/5-fluorouracil/irinotecan plus bevacizumab (FOLFIRI-BV) in patients with previously untreated metastat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e1fa6835f0e00a9065f0f1d71f6e1fe7
https://doi.org/10.1158/1078-0432.ccr-18-1221
https://doi.org/10.1158/1078-0432.ccr-18-1221
Publikováno v:
BMJ Open Ophthalmology
ObjectiveTo determine the time to first clinically meaningful improvement in best-corrected visual acuity (BCVA) in patients treated with ranibizumab for diabetic macular oedema (DME) and identify predictors of early visual improvement.Methods and an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab62908159f7184ad2a384affef6382b
http://europepmc.org/articles/PMC6830470
http://europepmc.org/articles/PMC6830470
Autor:
Aeron C. Hurt, Simon Portsmouth, Michael G. Ison, Jinnie Ko, Frederick G. Hayden, Klaus Kuhlbusch, Linda Yau, Rita de Cassia Castro
Publikováno v:
Metabolism. 116:154624
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::919addbdbdadde7a37b309cc0e2e729f
https://doi.org/10.1016/j.metabol.2020.154624
https://doi.org/10.1016/j.metabol.2020.154624
Publikováno v:
Retina. 34:2242-2249
To evaluate the incidence of collateral vessel formation and to determine their impact on best-corrected visual acuity and central foveal thickness in patients with branch or central retinal vein occlusion (BRVO, CRVO) receiving 0.3 mg or 0.5 mg of r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b6e28cdd1ea48ad251f89140cf7b6e4
https://doi.org/10.1097/iae.0000000000000209
https://doi.org/10.1097/iae.0000000000000209
Publikováno v:
Ophthalmology. 121(5):1059-1066
Purpose To assess time to first achievement of clinically significant visual acuity (VA) gains from baseline in patients with retinal vein occlusion (RVO) receiving ranibizumab versus sham treatment. Design Post hoc analyses of 2 phase 3 clinical tri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d672271aeeaf7ce96ef21dbe5223432